zm 230487 has been researched along with calcimycin in 1 studies
| Studies (zm 230487) | Trials (zm 230487) | Recent Studies (post-2010) (zm 230487) | Studies (calcimycin) | Trials (calcimycin) | Recent Studies (post-2010) (calcimycin) |
|---|---|---|---|---|---|
| 17 | 0 | 0 | 11,946 | 40 | 444 |
| Protein | Taxonomy | zm 230487 (IC50) | calcimycin (IC50) |
|---|---|---|---|
| XBP1 | Homo sapiens (human) | 1.41 | |
| DNA damage-inducible transcript 3 protein | Mus musculus (house mouse) | 0.16 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fischer, L; Rådmark, O; Steinhilber, D; Szellas, D; Werz, O | 1 |
1 other study(ies) available for zm 230487 and calcimycin
| Article | Year |
|---|---|
Phosphorylation- and stimulus-dependent inhibition of cellular 5-lipoxygenase activity by nonredox-type inhibitors.
Topics: Arachidonate 5-Lipoxygenase; Arsenites; Benzeneacetamides; Bridged Bicyclo Compounds; Calcimycin; Calcium; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Inhibitors; HeLa Cells; Humans; Hydroxamic Acids; Lipoxygenase Inhibitors; Mitogen-Activated Protein Kinases; Mutation, Missense; Neutrophils; Peroxides; Phloroglucinol; Phosphorylation; Pyrans; Quinolines; Quinolones; Sodium Chloride; Sodium Compounds; Terpenes | 2003 |